Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovaza effect on platelet function
NCT00515541Phase 2Completed
- Sponsor
- Invitrox
- Start
- Sep 2007
- Primary completion
- Jun 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of eicosapentaenoic acid + docosahexaenoic acid in cardiovascular disease (CVD), sponsored by Invitrox. Started Sep 2007; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT00515541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00515541.